Why the study?
Does dextran/aspirin compared to heparin/dihydroergotamine reduce the incidence of deep venous thrombosis in patients undergoing surgery for fracture of the femoral neck?
Does dextran/aspirin compared to heparin/dihydroergotamine reduce the incidence of deep venous thrombosis in patients undergoing surgery for fracture of the femoral neck?
In patients undergoing surgery for femoral neck fracture, a heparin/dihydroergotamine regimen is preferable to dextran/aspirin as it is safer with fewer hemorrhagic complications and similarly effective in preventing DVT.
Answers are grounded in this paper and cite their sources.
Similar DVT rates support comparable efficacy of both regimens; confirms equivalence for prophylaxis in femoral neck fracture surgery.
In a randomised trial we compared the effects of two different antithrombotic regimens on the incidence of venographically established deep venous thrombosis (DVT) in 83 patients undergoing surgery for fracture of the femoral neck. Group A received dextran 40 peroperatively plus 0.5 g aspirin a day beginning before operation and continuing for 10 days after. Group B received heparin calcium 5000 iu subcutaneously plus dihydroergotamine (DHE) 0.5 mg intramuscularly, given 8-hourly, beginning before operation and continuing for 10 days after. Two patients in Group A and three in Group B developed proximal DVT, while the incidence of all DVT was 33% in Group A and 29% in Group B, a difference which was not significant. Haemorrhagic complications were much more common in the dextran/aspirin group: the volume of drainage fluid, the number of patients transfused and quantity of blood transfused, and the drop in haemoglobin level were all significantly greater in Group A. We conclude that the DHE/heparin regime is preferable to dextran/aspirin because it is safer and no less effective.
No takes yet. Share an insight, caveat, or question.
Pini et al. (1985) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: